Publications by authors named "Fumie Hosoda"

42Publications

Integrated genetic and epigenetic analysis of myxofibrosarcoma.

Nat Commun 2018 07 17;9(1):2765. Epub 2018 Jul 17.

Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-03891-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050269PMC
July 2018

Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.

Genes Chromosomes Cancer 2017 10 27;56(10):711-718. Epub 2017 Jul 27.

Division of Cancer Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22469DOI Listing
October 2017

Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.

Hepatology 2014 Apr 18;59(4):1427-34. Epub 2014 Feb 18.

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.26890DOI Listing
April 2014

Signatures of mutational processes in human cancer.

Nature 2013 Aug 14;500(7463):415-21. Epub 2013 Aug 14.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776390PMC
August 2013

Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.

Pancreas 2009 Oct;38(7):e200-6

National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0b013e3181b8feb0DOI Listing
October 2009

Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.

Carcinogenesis 2009 Nov 4;30(11):1857-64. Epub 2009 Sep 4.

Cancer Genomics Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgp206DOI Listing
November 2009

Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.

Gastroenterology 2007 Nov;133(5):1475-86

Cancer Genomics Project, National Cancer Center Research Institute, Tokyo, Japan; Pathology Division, National Cancer Center Research Institute, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2007.08.038DOI Listing
November 2007

Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.

Cancer Res 2006 May;66(9):4617-26

Department of Molecular Cytogenetics, Medical Research Institute and Graduate School of Biomedical Science, Tokyo Medical and Dental University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-4437DOI Listing
May 2006

Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.

Cancer Res 2005 Nov;65(22):10233-42

Department of Molecular Cytogenetics, Medical Research Institute and Graduate School of Biomedical Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1073DOI Listing
November 2005

Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.

J Hepatol 2005 Nov 5;43(5):863-74. Epub 2005 Jul 5.

Pathology Division, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, and Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2005.05.033DOI Listing
November 2005

ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.

Oncogene 2005 Dec;24(54):8051-60

Department of Molecular Cytogenetics, Medical Research Institute and School of Biomedical Science, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208952DOI Listing
December 2005